47
total announcements
LUPIN.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 16 Oct 2026
Market Cap
₹90,585 Cr
P/E (TTM)
16.4
P/E (Forward)
19.5
EPS (TTM)
₹120.73
52W Low
₹1,900.00
52W High
₹2,529.50
Dividend Yield
0.92%
Beta
0.17
Price / Book
4.0
Debt / Equity
29.4
Revenue (TTM)
₹29,967 Cr
Gross Margin
72.36%
Operating Margin
25.35%
Lupin Limited
Lupin Limited has made the audio recording of its Q1 FY27 earnings call available on its website.
Lupin Limited
Lupin Limited has released its Q1 FY27 investor presentation, highlighting strong revenue growth and healthy EBITDA margins. The company has launched several new products, including Azilsartan Medoxomil and Ranibizumab, and received approvals for its products in various markets.
Lupin Limited
Lupin Limited has released its Q1 FY27 results, showing strong revenue growth with healthy EBITDA margins. The company has launched several new products, including Azilsartan Medoxomil, Ranibizumab, and Luforbec, and has received approvals for its products in various markets, including the US and China.
Lupin Limited
Lupin Limited has announced its Q1 FY2027 results, reporting a 33.3% YoY growth in sales to INR 82,172 Mn, with EBITDA up 42.8% to INR 25,799 Mn. The company's gross margin expanded to 74.6% and PBT increased 42.5% to INR 20,174 Mn. The company received 6 ANDA approvals from the US FDA and launched 3 products in the US market.
Lupin Limited
Lupin Limited has submitted unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with revenue from operations at ₹71,719.0 crore, and net profit after tax at ₹27,146.0 crore.
Lupin Limited
Lupin Limited has informed the Exchange regarding the Proceedings of the Forty-Fourth Annual General Meeting held on August 04, 2026. The Company has submitted the Exchange a copy of consolidated Scrutinizer's report along with voting results.
Lupin Limited
Lupin Limited has received approval from the US FDA for its Abbreviated New Drug Application for Diazepam Injection USP, 10 mg/2 mL (5 mg/mL), Single-Dose Prefilled Syringes.
Lupin Limited
Lupin Limited has announced the U.S. FDA approval and launch of Sugammadex Injection, a bioequivalent to Bridion Injection of Merck, for the reversal of neuromuscular blockade in adults and pediatric patients undergoing surgery.
Lupin Limited
Lupin Limited has informed the Exchange about the schedule of their earnings call for Q1 FY27, to be held on August 07, 2026, at 16:30 hrs (IST).
Lupin Limited
Lupin Limited
Lupin Limited has informed the Exchange about a copy of Newspaper Publication relating to Annual General Meeting and e-voting related information.
Lupin Limited
Lupin Limited has been recognized as one of India's Best Employers in the Nation-Builders Category by Great Place To Work India 2026, ranking among the top 14 organizations nationally.
Lupin Limited
Lupin Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report of the Company for FY 2025-26'.
Lupin Limited
Lupin Limited has informed the Exchange regarding Notice of the Forty-Fourth Annual General Meeting of the Company and Integrated Report for FY 2025-26.
Lupin Limited
Lupin Limited has informed the Exchange about a copy of Newspaper Advertisement relating to Annual General Meeting, Record Date, and other related information.
Lupin Limited
Lupin Limited has announced the record date for the purpose of dividend payment as July 17, 2026, for a final dividend of ₹ 18 per equity share.
Lupin Limited
Lupin Limited has informed the Exchange regarding Intimation of the Forty-Fourth Annual General Meeting to be held on August 04, 2026, and record date for payment of final dividend of ₹ 18 per equity share.
Lupin Limited
Lupin Limited has informed the Exchange regarding the allotment of 2358 shares under the ESOP (Employee Stock Option Plan) to its employees and subsidiaries.
Lupin Limited
Lupin Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the acceptance or rejection of dematerialized securities and listing of securities on stock exchanges.
Lupin Limited
Lupin Limited has been named among the world's most sustainable companies by TIME and Statista, ranking 318th among 750 companies selected from over 5,000 of the world's largest and most influential organizations.